Faculty of Medicine, Coimbra Institute for Clinical and Biomedical Research (iCBR), University of Coimbra, Coimbra, Portugal.
Institute of Pharmacology and Experimental Therapeutics, Faculty of Medicine, University of Coimbra, Coimbra, Portugal.
Adv Exp Med Biol. 2023;1415:21-26. doi: 10.1007/978-3-031-27681-1_4.
Matrix metalloproteinases (MMPs) are a tightly regulated family of proteolytic enzymes that break down extracellular matrix (ECM) and basement membrane components. Because it is associated with development, morphogenesis, tissue remodeling, and repair, ECM remodeling is an important mechanism. MMPs are thought to act as a double-edged sword, as they contribute to maintaining photoreceptors/retinal pigment epithelium (RPE)/Bruch's membrane (BM)/choroid complex homeostasis and also contribute to the onset and progression of age-related macular degeneration (AMD). Polymorphisms and/or altered expression in MMPs and their tissue inhibitors (TIMPs) are associated with age-related macular degeneration (AMD). Here, we review the evidence for MMPs' role in the onset and progression of AMD via addressing their regulation and TIMPs' significant regulatory functions.
基质金属蛋白酶(MMPs)是一类受到严格调控的蛋白水解酶家族,能够分解细胞外基质(ECM)和基底膜成分。由于 ECM 重塑与发育、形态发生、组织重塑和修复有关,因此它是一种重要的机制。MMPs 被认为是一把双刃剑,因为它们有助于维持光感受器/视网膜色素上皮(RPE)/Bruch 膜(BM)/脉络膜复合物的内稳态,也有助于年龄相关性黄斑变性(AMD)的发生和进展。MMPs 及其组织抑制剂(TIMPs)的多态性和/或表达改变与年龄相关性黄斑变性(AMD)有关。在这里,我们通过探讨 MMPs 的调节以及 TIMPs 的重要调节功能,综述了 MMPs 在 AMD 发生和进展中的作用的证据。